Kobayashi Pharmaceutical Co Ltd
TSE:4967
Kobayashi Pharmaceutical Co Ltd
TSE:4967
Price:
5 350 JPY
-0.56%
Market Closed
Updated:
May 8, 2024
Kobayashi Pharmaceutical Co Ltd
Net Income (Common)
|
Kobayashi Pharmaceutical Co Ltd
Net Income (Common) Peer Comparison
Comparables:
4911
4527
4927
4452
F
4921
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Kobayashi Pharmaceutical Co Ltd
TSE:4967
|
Net Income (Common)
¥20.3B
|
CAGR 3-Years
2%
|
CAGR 5-Years
2%
|
CAGR 10-Years
7%
|
|
|
Shiseido Co Ltd
TSE:4911
|
Net Income (Common)
¥21.7B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-19%
|
CAGR 10-Years
N/A
|
|
|
Rohto Pharmaceutical Co Ltd
TSE:4527
|
Net Income (Common)
¥30.9B
|
CAGR 3-Years
32%
|
CAGR 5-Years
25%
|
CAGR 10-Years
13%
|
|
|
Pola Orbis Holdings Inc
TSE:4927
|
Net Income (Common)
¥9.7B
|
CAGR 3-Years
28%
|
CAGR 5-Years
3%
|
CAGR 10-Years
3%
|
|
|
Kao Corp
TSE:4452
|
Net Income (Common)
¥43.9B
|
CAGR 3-Years
-30%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
-4%
|
|
F
|
Fancl Corp
TSE:4921
|
Net Income (Common)
¥7.6B
|
CAGR 3-Years
0%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
See Also
What is Kobayashi Pharmaceutical Co Ltd's Net Income (Common)?
Net Income (Common)
20.3B
JPY
20.3B
JPY
Based on the financial report for Dec 31, 2023, Kobayashi Pharmaceutical Co Ltd's Net Income (Common) amounts to 20.3B JPY.
What is Kobayashi Pharmaceutical Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
7%
7%
Over the last year, the Net Income (Common) growth was 2%. The average annual Net Income (Common) growth rates for Kobayashi Pharmaceutical Co Ltd have been 2% over the past three years , 2% over the past five years , and 7% over the past ten years .
You don't have any saved screeners yet
